TNF and rheumatoid arthritis: Patients and disease phenotypes: In a study where 42% of patients stopped therapy, increased likelihood of discontinuation was associated with higher physician global scores and RA Disease Activity Index scores 6 months prior to stopping the TNF inhibitor, and a higher number of TNF inhibitors used previously.